OCTRI announces 2015 Biomedical Innovation Program award recipients

The Oregon Clinical & Translational Research Institute (OCTRI) is pleased to announce the funding of three research awards through its Biomedical Innovation Program. The program cultivates and...

Catalyst Award applications due Mar. 31

Applications for the Oregon Clinical & Translational Research Institute (OCTRI) Catalyst Awards are due Mar. 31, 2015. This pilot project funding is designed to facilitate novel, collaborative,...

OCTRI Research Forum: Survey design and tools part II, Mar. 12

Join the Oregon Clinical and Translational Research Institute, OCTRI, in a monthly research forum that addresses all things clinical and translational research. Don’t miss March's topic:...

OCTRI Design Studio: Get feedback on your project from senior faculty

Are you submitting a Career Development K award? Or your first R01? A similar major grant? The Oregon Clinical and Translational Research Institute has an opportunity for basic and clinical...

OCTRI Research Forum: Power and Sample Size Simplified, Dec. 12

Join the Oregon Clinical and Translational Research Institute, OCTRI, in a monthly research forum that addresses all things clinical and translational research. Don’t miss December’s topic:...

Internal applications for Mary Kay Cancer Research Award due Dec. 19

The purpose of the Mary Kay Ash Foundation Innovative/Translational Cancer Research Award is to fund research in ovarian, uterine, breast, or cervical cancer. Translational research is broadly...

Letters of Intent for OCTRI biomedical innovation program due Nov. 12

The Oregon Clinical & Translational Research Institute (OCTRI) is now accepting letters of intent to apply for its Biomedical Innovation Program. The program cultivates and selects promising...

NIH Common Fund Video Competition winners announced

Did you know that the NIH Common Fund was holding a video competition to commemorate its 10-year anniversary? Neither did we, but after seeing this Common Fund rap, we will definitely be going with...